sodium iodide i-123
Small moleculeapprovedImaging agent
Approved
Mar 24, 1976
Clinical trial activity
0 trials · 0 clinical orgs · 4 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1970s
- Mar 24, 1976
General Electric — Earliest FDA Approval
- Mar 24, 1976
General Electric — NDA Secondary Org
- Mar 24, 1976
General Electric — NDA Organization
1980s
- May 27, 1982
Cardinal Health — NDA Secondary Org
- Feb 28, 1989
Curium Pharma — Marketing Organization
- Feb 28, 1989
Mallinckrodt — Marketing Organization
Indications
Approved for
Mechanism of action
- Unspecified targetRadiopharmaceutical
Radiopharmaceutical
Approval history
- approvedPriority reviewMar 24, 1976
Chemistry & pharmacology
Loading structure…
SMILES
[123I-].[Na+]- Mol. weight
- 145.9 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- Yes
- Polymer
- No
- Delivery
- Oral
- Availability
- Prescription Only
- Imaging
- 123-iodine
Oral
Yes
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3707217 ↗
- ChEMBLCHEMBL1201083 ↗
Also known as
- sodium iodide (123i)
- sodium iodide (123i)
- sodium iodide (123i) capsules
- sodium iodide (123i) capsules
- sodium iodide (124i)
- sodium iodide (124i)
- sodium iodide i 123
- sodium iodide i 123
- sodium iodide i-123
- sodium iodide i-123
- sodium iodide i-123
Organizations
Marketing (5)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Cardinal Health | Academic/Hospital | NDA2 | May 27, 1982 |
| Curium Pharma | For profit | MKTG | Feb 28, 1989 |
| General Electric | For profit | NDA2 | Mar 24, 1976 |
| General Electric | For profit | NDA | Mar 24, 1976 |
| Mallinckrodt | For profit | MKTG | Feb 28, 1989 |